---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-035553"
form_type: "8-K"
ticker: "CODX"
cik: "0001692415"
company_name: "Co-Diagnostics, Inc."
filed_at: "2026-07-31T12:30:15+00:00"
generated_at: "2026-07-31T12:35:13.691951+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Co-Diagnostics raises ~$2.67M via warrant exercise; issues new warrants for 3.4M shares

## Summary
- Gross proceeds of ~$2.67M from cash exercise of 1,702,362 existing warrants at $1.571/share.
- New warrants to purchase up to 3,404,724 shares at $1.56/share, exercisable only after stockholder approval.
- Outstanding shares to increase from 5,277,846 to 6,980,208 after the exercise.
- Placement agent Maxim Group LLC receives 7% cash fee and $50,000 expense reimbursement.
- Net proceeds to be used for general corporate purposes.

## SEC filing metadata
- accession: 0001493152-26-035553
- form_type: 8-K
- ticker: CODX
- cik: 0001692415
- company_name: Co-Diagnostics, Inc.
- filed_at: 2026-07-31T12:30:15+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1692415/000149315226035553/0001493152-26-035553-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1692415/000149315226035553/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-035553
- JSON: https://secwatch.observer/filing/0001493152-26-035553.json
- Plain text: https://secwatch.observer/filing/0001493152-26-035553.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.